UBS Group’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$109M Sell
3,942,232
-2,435,305
-38% -$67.2M 0.02% 737
2025
Q1
$181M Buy
6,377,537
+1,304,166
+26% +$37M 0.03% 463
2024
Q4
$211M Buy
5,073,371
+2,804,243
+124% +$117M 0.04% 393
2024
Q3
$152M Buy
2,269,128
+1,187,367
+110% +$79.4M 0.03% 397
2024
Q2
$128M Buy
1,081,761
+64,573
+6% +$7.67M 0.03% 414
2024
Q1
$108M Buy
1,017,188
+143,919
+16% +$15.3M 0.03% 461
2023
Q4
$86.8M Sell
873,269
-119,743
-12% -$11.9M 0.03% 466
2023
Q3
$103M Buy
993,012
+256,471
+35% +$26.5M 0.04% 367
2023
Q2
$89.5M Buy
736,541
+182,377
+33% +$22.2M 0.03% 423
2023
Q1
$85.1M Buy
554,164
+104,588
+23% +$16.1M 0.03% 405
2022
Q4
$80.8M Buy
449,576
+137,479
+44% +$24.7M 0.03% 427
2022
Q3
$36.9M Sell
312,097
-115,255
-27% -$13.6M 0.02% 634
2022
Q2
$61M Buy
427,352
+62,194
+17% +$8.88M 0.03% 475
2022
Q1
$62.9M Sell
365,158
-346,161
-49% -$59.6M 0.02% 532
2021
Q4
$181M Sell
711,319
-51,687
-7% -$13.1M 0.05% 264
2021
Q3
$294M Buy
763,006
+348,592
+84% +$134M 0.09% 171
2021
Q2
$97.4M Sell
414,414
-51,919
-11% -$12.2M 0.03% 411
2021
Q1
$61.1M Buy
466,333
+135,544
+41% +$17.7M 0.02% 536
2020
Q4
$34.6M Buy
330,789
+43,258
+15% +$4.52M 0.01% 749
2020
Q3
$20.3M Buy
287,531
+14,974
+5% +$1.06M 0.01% 903
2020
Q2
$17.5M Buy
272,557
+167,322
+159% +$10.7M 0.01% 916
2020
Q1
$3.15M Buy
105,235
+94,626
+892% +$2.83M ﹤0.01% 1819
2019
Q4
$208K Sell
10,609
-49,245
-82% -$965K ﹤0.01% 4578
2019
Q3
$952K Buy
59,854
+34,320
+134% +$546K ﹤0.01% 3228
2019
Q2
$374K Buy
25,534
+16,149
+172% +$237K ﹤0.01% 3727
2019
Q1
$191K Buy
9,385
+7,185
+327% +$146K ﹤0.01% 3869
2018
Q4
$34K Buy
+2,200
New +$34K ﹤0.01% 5480